Dec 15, 2020 Dr. Seth Lederman interviewed by Christine Corrado of Proactive Investors to discuss the positive Phase 3 results from its fibromyalgia trial using TNX-102 SL
Dec 4, 2020 Dr. Seth Lederman interviewed by Christine Corrado of Proactive Investors to discuss the similarities between a circa 1860 U.S. smallpox vaccine and horsepox virus
Dec 4, 2020 Dr. Seth Lederman interviewed on Contagion Live to discuss its COVID-19 vaccine in development.
Aug 11, 2020 Dr. Seth Lederman presents a vaccine tutorial covering the challenges and opportunities of developing a vaccine for COVID-19
Jul 17, 2020 Dr. Seth Lederman interviewed by Christine Corrado of Proactive Investors to discuss strategic partnerships in developing vaccines for COVID-19
Jul 8, 2020 Dr. Seth Lederman interviewed by Jane King on New to the Street to discuss Tonix’s portfolio of product candidates to fight COVID-19
Jul 8, 2020 Dr. Seth Lederman interviewed on Bloomberg TV to discuss the goals & timeline for development of TNX-1800, Tonix’s live replicating COVID-19 vaccine candidate.
Jun 17, 2020 Seth Lederman interviewed by KWTX’s Haley Vyrostek about Tonix’s partnership with Fujifilm Diosynth to manufacture and develop their COVID-19 vaccine candidate, TNX-1800, for clinical trial supply.
Jun 1, 2020 New York City based pharmaceutical company chooses College Station to manufacture possible coronavirus vaccine
May 28, 2020 Tonix Pharmaceuticals Discusses Developing COVID-19 Vaccine in Collaboration with Southern Research
Apr 21, 2020 MicroCap Investing Workshop: Potential Solutions for Addressing the Coronavirus Pandemic
